临床实践
Copyright ©The Author(s) 2024.
世界华人消化杂志. 2024-10-28; 32(10): 750-757
在线出版 2024-10-28. doi: 10.11569/wcjd.v32.i10.750
表1 2组一般资料比较[mean±SD, n(%)]
项目死亡组(n = 42)生存组(n = 171)t/χ2P
男性/女性28/14118/530.0860.770
年龄(岁)69.03±3.4167.95±4.331.5050.134
BMI(kg/m2)22.23±1.0821.91±1.351.4270.155
24 h出血量(mL)626.63±112.24603.13±100.171.3300.185
GBS评分(分)9.15±1.677.06±1.149.628<0.001
原发疾病0.4730.789
胃溃疡22(52.38)82(47.95)
急慢性胃炎17(40.48)79(46.20)
肝硬化3(7.14)10(5.85)
合并疾病
高血压14(33.33)56(32.75)0.0050.942
糖尿病16(38.10)54(31.58)0.6480.421
冠心病4(9.52)13(7.60)0.0080.925
7 d内再出血8(19.05)4(2.34)14.706<0.001
吸烟史17(40.48)61(35.67)0.3350.562
H. pylori感染22(52.38)53(30.99)6.7610.010
饮酒史9(21.43)33(19.30)0.0970.756
口服药物
抗血小板药物12(28.57)44(25.73)0.1400.708
非甾体消炎药4(9.52)20(11.70)0.0180.900
表2 2组血清学指标比较(mean±SD)
组别MCP-1(pg/mL)S100A12(ng/mL)BUN/CrPLT(×109/L)Hb(g/L)RDW(%)INR
死亡组(n = 42)135.56±14.8820.04±5.28130.32±26.2489.92±8.8975.78±8.1216.17±2.861.58±0.47
生存组(n = 171)95.91±12.2415.15±4.5084.84±15.6691.04±10.1580.65±7.7815.36±3.281.12±0.33
t17.9936.09114.5080.6563.6041.4687.389
P<0.001<0.001<0.0010.513<0.0010.143<0.001
表3 共线性诊断结果
自变量维度容忍度方差膨胀因子
GBS评分10.56811.234
H. pylori感染20.41110.687
7 d内再出血30.43212.749
MCP-140.8441.021
BUN/Cr50.7121.356
Hb60.3651.240
INR70.8031.779
S100A1280.9031.351
表4 AUGIB患者疾病转归影响因素
自变量赋值βS.E.Wald χ2POR95%CI
下限上限
MCP-1实测值1.5020.34618.834<0.0014.4891.64212.271
S100A12实测值1.3050.29819.170<0.0013.6871.34510.106
BUN/Cr实测值1.1020.32111.776<0.0013.0091.1278.033
INR实测值1.1220.27117.146<0.0013.0711.1138.476
常数项-1.2870.36712.298<0.0013.6221.20510.887
表5 无创血清学模型预测AUGIB患者疾病转归价值
项目AUC95%CI敏感度特异度P
MCP-10.8070.748-0.85888.20%61.40%<0.001
BUN/Cr0.8210.763-0.87083.00%71.93%<0.001
S100A120.7880.727-0.84188.55%63.16%<0.001
INR0.7590.696-0.81571.43%70.18%<0.001
无创血清学模型0.9360.894-0.95688.10%85.96%<0.001
表6 无创血清学模型的前瞻性验证n(%)
实际结果无创血清学模型
合计预测准确率
死亡生存
死亡941369.23
生存2414395.35
合计11455689.28

引文著录: 徐艺宸, 陈慧兰, 毛云. 无创血清学模型对急性上消化道出血患者疾病转归的预测价值. 世界华人消化杂志 2024; 32(10): 750-757